Furthermore, elevated PRKCH was associated with better survival in ACC, CESC, CHOL, HNSC, KIRC, LIHC, LUAD, and PRAD, but worsened BLCA and LGG patients’ prognosis. This evidence concerns the gene PRKCH and bladder transitional cell carcinoma.